Notice2026-10021

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 19, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 96 (Tuesday, May 19, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 96 (Tuesday, May 19, 2026)]
[Notices]
[Pages 29147-29148]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-10021]



[[Page 29147]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Reproductive, Perinatal and Pediatric Health.
    Date: June 4, 2026.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Sheila Pirooznia, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-9350, 
<a href="/cdn-cgi/l/email-protection#5e2d363b37323f702e372c31312430373f1e30373670393128"><span class="__cf_email__" data-cfemail="75061d101c19145b051c071a1a0f1b1c14351b1c1d5b121a03">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Cancer Therapeutics and Drug Development.
    Date: June 22, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6192, Bethesda, MD 20892, 301-451-0131, 
<a href="/cdn-cgi/l/email-protection#4a263e253a25260a272b232664242322642d253c"><span class="__cf_email__" data-cfemail="a1cdd5ced1cecde1ccc0c8cd8fcfc8c98fc6ced7">[email&#160;protected]</span></a>.

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Gene Regulation in Cancer Study Section.
    Date: June 22-23, 2026.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Manzoor A. Zarger, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6208, Bethesda, MD 20892, (301) 
435-2477 <a href="/cdn-cgi/l/email-protection#e69c87948183948b87a6859594c8888f8ec8818990"><span class="__cf_email__" data-cfemail="0c766d7e6b697e616d4c6f7f7e22626564226b637a">[email&#160;protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; Immune Mechanisms of Hypersensitivity and 
Allergy Study Section.
    Date: June 23, 2026.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Deanna C. Bublitz, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4005, 
<a href="/cdn-cgi/l/email-protection#b9dddcd8d7d7d897dbccdbd5d0cdc3f9d7d0d197ded6cf"><span class="__cf_email__" data-cfemail="721617131c1c135c1007101e1b0608321c1b1a5c151d04">[email&#160;protected]</span></a>.

    Name of Committee: Applied Therapeutics for Cancer Integrated 
Review Group; Mechanisms of Cancer Therapeutics B Study Section.
    Date: June 24, 2026.
    Time: 8:30 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Maria Dolores Arjona Mayor, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 806D, Bethesda, MD 20892, (301) 
827-8578, <a href="/cdn-cgi/l/email-protection#bedad1d2d1ccdbcd90dfccd4d1d0dfd3dfc7d1ccfed0d7d690d9d1c8"><span class="__cf_email__" data-cfemail="680c0704071a0d1b46091a02070609050911071a28060100460f071e">[email&#160;protected]</span></a>.

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Biochemical and Cellular Oncogenesis Study Section.
    Date: June 24, 2026.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jian Cao, MD, Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892, (301) 827-5902, <a href="/cdn-cgi/l/email-protection#187b79777276587b6b6a36767170367f776e"><span class="__cf_email__" data-cfemail="d5b6b4babfbb95b6a6a7fbbbbcbdfbb2baa3">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Medical Imaging Research.
    Date: June 24, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Debanjan Goswami, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Office 810-G, Bethesda, MD 20892, 
(301) 451-1587, <a href="/cdn-cgi/l/email-protection#bfdbdaddded1d5ded191d8d0ccc8ded2d6ffd1d6d791d8d0c9"><span class="__cf_email__" data-cfemail="60040502010e0a010e4e070f1317010d09200e09084e070f16">[email&#160;protected]</span></a>.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Pathophysiology of Eye Disease--2 Study 
Section.
    Date: June 24-25, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Barbara Susanne Mallon, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-8992, 
<a href="/cdn-cgi/l/email-protection#5a373b36363534381a373b333674343332743d352c"><span class="__cf_email__" data-cfemail="335e525f5f5c5d51735e525a5f1d5d5a5b1d545c45">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR'S: Proteostasis and Protein Aggregation in 
Neurodegeneration (PPAN).
    Date: June 24-25, 2026.
    Time: 9:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jennifer Kielczewski, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042, 
<a href="/cdn-cgi/l/email-protection#abc1cec5c5c2cdced985c0c2cec7c8d1cedcd8c0c2ebc5c2c385ccc4dd"><span class="__cf_email__" data-cfemail="93f9f6fdfdfaf5f6e1bdf8faf6fff0e9f6e4e0f8fad3fdfafbbdf4fce5">[email&#160;protected]</span></a>.

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Drug and Biologic Therapeutic Delivery 
Study Section.
    Date: June 24, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Janice Duy, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-3139, 
<a href="/cdn-cgi/l/email-protection#660c07080f05034802131f26080f0e48010910"><span class="__cf_email__" data-cfemail="0a606b6463696f246e7f734a646362246d657c">[email&#160;protected]</span></a>.

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Healthcare and Health Disparities Study 
Section.
    Date: June 24, 2026.
    Time: 9:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Tara R. Earl, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1007C, Bethesda, MD 20817, (301) 402-6857, 
<a href="/cdn-cgi/l/email-protection#f5909487998187b598949c99db9b9c9ddb929a83"><span class="__cf_email__" data-cfemail="7a1f1b08160e083a171b131654141312541d150c">[email&#160;protected]</span></a>.

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Molecular and Cellular 
Neuropharmacology Study Section Molecular and Cellular 
Neuropharmacology Study Section.

[[Page 29148]]

    Date: June 24-25, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1009-E, Bethesda, MD 20892, (301) 435-5999, 
<a href="/cdn-cgi/l/email-protection#056767707f64764568646c692b6b6c6d2b626a73"><span class="__cf_email__" data-cfemail="bfddddcac5deccffd2ded6d391d1d6d791d8d0c9">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

     Dated: May 15, 2026.
Margaret N. Vardanian,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-10021 Filed 5-18-26; 8:45 am]
BILLING CODE 4167-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on May 19, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.